Showing 131 - 140 of 186 for "Pharmaceuticals%20and%20life%20sciences" with applied filters
06 August 2021 by
Covid-19 has disrupted our lives and businesses at many unprecedented levels never seen before in the history of mankind.
18 February 2021 by
Patentability of inventions involving usage of radioactive substances?
02 February 2021 by
The Greater Bay Area companies may choose to list in the A-shares market in Mainland China or Hong Kong. Small and medium-sized enterprises may also choose to list on GEM in Hong Kong which has relatively lower requirements for listing.
27 July 2023 by
With significant development in dietary supplements and alternative food industry in recent years, Korean government announced alternative food (e.g., plant-based meet, cultured meat, insect based meat, etc.), dietary supplement and medical food (i.e., specially formulated food for patients with certain symptoms or nutritional needs) as industry sectors for future development.
11 July 2023 by
RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.
20 April 2023 by
The Indian pharmaceutical market is one of the largest markets in the globe, both in terms of production and consumption. Several changes have been made to the patent and competition law due to the increasing challenges in the pharmaceutical market that directly impact the profit margin of pharmaceutical manufacturers. To increase these margins, pharmaceutical product manufacturing firms employ a variety of strategies. This article investigates the concept of “product hopping” and compares it with the practice of patent evergreening.
23 March 2023 by
It is generally known and understood that every exception in the act should stand on its own footing. Two seemingly similar provisions in legal sense cannot lean back on one another to fortify the argument favouring the exception or otherwise. This seemingly sound argument suffers the close scrutiny of the Delhi High court in Best Agrolife Limited v Deputy Controller of Patents & Anr (WP(C)-IPD 11/2022 & CM 32/2022, 54/2022, 55/2022).
21 February 2023 by
asialaw's Deal of the Month for February 2023 is...
21 February 2023 by
asialaw's Lawyer of the Month for February 2023 is...
02 February 2023 by
Pfizer Inc. and its group companies (“Pfizer”) filed a suit bearing no. CS (COMM) No. 442 of 2021 titled as Pfizer Inc. & Ors. v. Triveni Interchem Private Limited & Ors. before the Hon’ble Delhi High Court, for infringement of patent IN 218291 for the compound Palbociclib.
